High BCL2 protein in this disease[133], which results from deletion of genes encoding two microRNAs that target BCL2 mRNA[134,135], was taken as a sign that CLL might be dependent on BCL2 for survival and, therefore, sensitive to BCL2 inhibition. The gene discussed is BCL2; the disease is B-cell chronic lymphocytic leukemia.